Danaher Corporation (DHR)Director sold ~$114K
Alan G Spoon, Director at Danaher Corporation, sold ~$114K of Danaher Corporation shares.
- ~$114K
- Approx. value · 550 sh @ $206.46
- 121K
- Holds after · shares reported
- Traded
- Feb 7, 2025
- Filed
- Feb 10, 2025
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Jan 15, 2025CongressDisclosed sale of DHR — reported range $1,001 - $15,000
- Jan 30, 2025InsiderOfficer sold ~$1.28M of DHR shares in the open market
- Feb 7, 2025 · this disclosureInsiderDirector sold ~$114K of DHR shares in the open market
What came next
- Feb 13, 2025CongressDisclosed sale of DHR — reported range $15,001 - $50,000
- Feb 25, 2025CongressDisclosed sale of DHR — reported range $15,001 - $50,000
- Feb 26, 2025CongressDisclosed partial sale of DHR — reported range $1,001 - $15,000
- Mar 4, 2025CongressDisclosed purchase of DHR — reported range $1,001 - $15,000
- Mar 5, 2025FDAFDA device clearance: Access Cortisol; DxC 500i Clinical Analyzer
- Mar 17, 2025FDARecall: DxC 500 AU Clinical Chemistry Analyzer, Catalog Numbers/UDI codes: C63519 / 14987666545058 C63520 / 14987666545065 Software versions: V1.3, V1.4, V1.4.1, V1.4.…
- Mar 20, 2025FDARecall: DxC 500 AU Clinical Chemistry Analyzer, Catalog Numbers/UDI codes: C63519 / 14987666545058 C63520 / 14987666545065. The Beckman Coulter DxC 500 AU Clinical Che…
- Mar 21, 2025FDARecall: Radiometer ABL90 Series - Radiometer ABL90 FLEX Model Number 393-090 Radiometer ABL90 Series - Radiometer ABL90 FLEX PLUS Model Number 393-092 The Radiometer A…
- Mar 27, 2025FDARecall: Beckman Coulter DxI 9000 Access Immunoassay Analyzer
- Mar 27, 2025CongressDisclosed sale of DHR — reported range $1,001 - $15,000
- Mar 28, 2025FDAFDA device clearance: Access Toxo IgG
- Apr 2, 2025FDARecall: HistoCore PELORIS 3, Model/Catalog Number: 45.0005/45.7512.501 A11, Software Version: 3.4.0. The HistoCore PELORIS 3 Rapid Tissue Processor is a dual retort ra…
- Apr 7, 2025CongressDisclosed sale of DHR — reported range $15,001 - $50,000
- Apr 8, 2025FDARecall: REMISOL Advance UDI-DI code: 13700962601874 All Software Versions: B92487; B92488; C24317; C28652; C37500; D04164; C44703; C57017; C69412; C69413; C73942; C739…
- Apr 8, 2025CongressDisclosed purchase of DHR — reported range $15,001 - $50,000
- Apr 11, 2025CongressDisclosed partial sale of DHR — reported range $1,001 - $15,000
- Apr 21, 2025CongressDisclosed sale of DHR — reported range $1,001 - $15,000
- Apr 23, 2025FDARecall: Apo B Reagent, REF: OSR6143
- Apr 23, 2025FDARecall: DxI 9000 Access Immunoassay Analyzer, Catalog Number C11137, running software version 1.20
- Apr 23, 2025FDARecall: DxI 9000 Access Immunoassay Analyzer, Catalog Number C11137, running software versions 1.20
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Danaher Corporation
For Danaher Corporation, OQRO holds 3 insider filings (SEC Form 4 or Form 144), 3 Congress trade reports and 86 fund holdings reports (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DHR page.
Other recent filings by Alan G Spoon, Director
The full history of Alan G Spoon, Director is on the profile page.
How this filing works
Other disclosures at Danaher Corporation
- House Clerk periodic transaction reportSep 25, 2026
- House Clerk periodic transaction reportSep 25, 2026
- SEC Form 4Aug 24, 2026
- SEC Form 4Aug 24, 2026
- SEC Form 4Aug 24, 2026
- SEC Form 13F-HRAug 18, 2026
Everything OQRO holds on this company is on its DHR page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
